Stephens & Co. Downgrades BioLife Solutions to Equal-Weight, Lowers Price Target to $31
Jefferies Downgrades BioLife Solutions to Hold, Raises Price Target to $31
TD Cowen Downgrades BioLife Solutions to Hold, Lowers Price Target to $31
HC Wainwright & Co. Downgrades BioLife Solutions to Neutral, Lowers Price Target to $31
What Makes BioLife Solutions (BLFS) a Compelling Long-Term Hold?
A Look At BioLife Solutions (BLFS) Valuation As Shares Show Recent Short Term Momentum
BioLife (BLFS) Q1 2026 Earnings Transcript
BioLife Solutions, Inc. Q1 2026 Earnings Call Summary
BioLife Solutions, Inc. (BLFS) Q1 2026 Earnings Call Transcript
BioLife Solutions Q1 Earnings Call Highlights
BioLife Solutions Inc (NASDAQ:BLFS) Q1 2026 Earnings Beat Signals Profitability Milestone
BioLife Solutions Reports First Quarter 2026 Financial Results
BioLife Solutions to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026
BioLife Solutions Wins INTERPHEX 2026 Biotech Innovation Award for CellSeal® CryoCase
BioLife Looks Strong For Fiscal Year 2026
Wall Street Analysts Believe BioLife Solutions (BLFS) Could Rally 35%: Here's is How to Trade
Should BioLife Solutions’ 2026 Profitability Guidance and Refocus Require Action From BLFS Investors?
BioLife Solutions Inc (BLFS) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...
BioLife Solutions, Inc. Q4 2025 Earnings Call Summary
BioLife Solutions Inc (NASDAQ:BLFS) Surpasses Q4 2025 Estimates with Surprise Profit, Stock Rises
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.